InfographicThree Data Points We’re Watching This Week: AI Focus John Mercer, Head of Global Research and Managing Director of Data-Driven Research July 26, 2024 Reasons to ReadOur Three Data Points We’re Watching This Week series spotlights key data points from this week’s research. Discover data points we are watching in week 30 of 2024, with a focus on AI (artificial intelligence). From the impact of AI-based drug discovery to the estimated value of the global GenAI (generative AI) applications and hardware market by 2028, we offer key metrics from our research. Dive into the full research reports behind these data points: The Coresight Research AI Risk-Mitigation Framework AI in Action: Redefining Drug Discovery Harnessing GenAI: Strategic Approaches To Combat Risk—Insights from The Lead Summit 2024 Keep up to date with all our research reports on GenAI in retail Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Mapping the US’s Reciprocal Import Tariffs: Which Nations Are Affected?Holiday 2025: Government Shutdown-Related Reduction in SNAP, Other Payments and Salaries Could Meaningfully Impact US Holiday SpendingWeekly UK Store Openings and Closures Tracker 2025, Week 26: River Island To Close 30+ StoresNRF 2025: Retail’s Big Show Wrap-Up—The Future of Retail Will Be Driven by AI, Innovation and a Commitment to Sustainability
